Skip to main content

Table 11 Clinical information and functional assays results from three hypersensivity patients to antibiotics

From: 7th Drug hypersensitivity meeting: part two

Patient information

Lymphocyte transformation test

Change in the pattern of expresion of miRNAs with drugs

Code

Sex

Age

Skin reaction

SI/Drug (μg/ml)

miRNA

Drug (μg/ml)

Relative expression

Time (h)

SMX1

F

60

MPE

5.0/SMX (200)

5.2/SMX-NO (20)

142

SMX (400)

153 ± 28

12

     

18a

SMX-NO (12)

71.6 ± 1.21

24

     

155

SMX-NO (12)

5.6 ± 1.1

24

SMX2

M

35

MPE

2.0/SMX (400)

3.0/SMX-NO (20)

18a

SMX (400)

2.5 ± 0.6

24

     

21

SMX-NO (12)

6.3 ± 3.2

24

     

142

SMX (400)

3.9 ± 0.7

24

LVF1

M

47

MPE

2.0/LVF (10)

142

LVF (10)

12.2 ± 0.9

24

     

18a

LVF (10)

4.0 ± 0.4

48

     

155

LVF (10)

5.1 ± 1.1

48

  1. Relative expression results are presented as the Mean ± SD obtained by the delta Cq method
  2. SMX sulfamethoxazole, SMX-NO sulfamethoxazole nitroso, LVF levofloxacin, MPE maculopapular exanthema